| Application no. and date | 00913417.2 (espacenet) (Federated) (European Patent Register), 20000210 | | Patent/reg. no. and date | DK/EP 1189629, 20100929 | | Publication date | 20020327 | | Priority no. and date | US 119577 P, 19990210 | | EP pub. no. and date |
EP 1189629 20020327 | | Effective date | | | Applicant/owner | Curis, Inc., 4 Maguire Road
Lexington, MA 02421, US | | Applicant ref. no. | 140123 | | Inventor | PANG, Kevin, 45 Moulton Street
Cambridge, MA 02138, US,
LU, Huang-hui, 45 Moulton Street
Cambridge, MA 02138, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 38/22 (2006.01) , A61P 3/06 (2006.01) , A61P 3/08 (2006.01) , A61P 5/48 (2006.01) , C12N 5/071 (2010.01) , G01N 33/50 (2006.01) | | Title | Peptid YY (PYY) til behandling af glucosestofskiftesygdomme | | Int. application no. | US2000003391 | | Int. publication no. | WO2000047219 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
